Procept Biorobotics Corp (PRCT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.35 is considered Undervalued compared with the five-year average of -27.71. The fair price of Procept Biorobotics Corp (PRCT) is between 123.46 to 197.81 according to relative valuation method. Compared to the current price of 25.90 USD , Procept Biorobotics Corp By Undervalued By 79.02%.

Relative Value

Fair Zone

123.46-197.81

Current Price：25.90

79.02%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Procept Biorobotics Corp (PRCT) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Procept Biorobotics Corp (PRCT) has a current Price-to-Book (P/B) ratio of 4.52. Compared to its 3-year average P/B ratio of 9.84, the current P/B ratio is approximately -54.08% higher. Relative to its 5-year average P/B ratio of 8.68, the current P/B ratio is about -47.91% higher. Procept Biorobotics Corp (PRCT) has a Forward Free Cash Flow (FCF) yield of approximately -4.64%. Compared to its 3-year average FCF yield of -4.65%, the current FCF yield is approximately -0.15% lower. Relative to its 5-year average FCF yield of -4.50%, the current FCF yield is about 3.18% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for PRCT competitors is 67.66, providing a benchmark for relative valuation. Procept Biorobotics Corp Corp (PRCT.O) exhibits a P/S ratio of 4.35, which is -93.58% above the industry average. Given its robust revenue growth of 11.94%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of PRCT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of PRCT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PRCT currently overvalued or undervalued?

Procept Biorobotics Corp (PRCT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.35 is considered Undervalued compared with the five-year average of -27.71. The fair price of Procept Biorobotics Corp (PRCT) is between 123.46 to 197.81 according to relative valuation method. Compared to the current price of 25.90 USD, Procept Biorobotics Corp is Undervalued By 79.02%.

What is Procept Biorobotics Corp (PRCT) fair value?

PRCT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Procept Biorobotics Corp (PRCT) is between 123.46 to 197.81 according to relative valuation method.

How does PRCT's valuation metrics compare to the industry average?

The average P/S ratio for PRCT's competitors is 67.66, providing a benchmark for relative valuation. Procept Biorobotics Corp Corp (PRCT) exhibits a P/S ratio of 4.35, which is -93.58% above the industry average. Given its robust revenue growth of 11.94%, this premium appears unsustainable.

What is the current P/B ratio for Procept Biorobotics Corp (PRCT) as of Mar 02 2026?

As of Mar 02 2026, Procept Biorobotics Corp (PRCT) has a P/B ratio of 4.52. This indicates that the market values PRCT at 4.52 times its book value.

What is the current FCF Yield for Procept Biorobotics Corp (PRCT) as of Mar 02 2026?

As of Mar 02 2026, Procept Biorobotics Corp (PRCT) has a FCF Yield of -4.64%. This means that for every dollar of Procept Biorobotics Corp's market capitalization, the company generates -4.64 cents in free cash flow.

What is the current Forward P/E ratio for Procept Biorobotics Corp (PRCT) as of Mar 02 2026?

As of Mar 02 2026, Procept Biorobotics Corp (PRCT) has a Forward P/E ratio of -25.92. This means the market is willing to pay $-25.92 for every dollar of Procept Biorobotics Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Procept Biorobotics Corp (PRCT) as of Mar 02 2026?

As of Mar 02 2026, Procept Biorobotics Corp (PRCT) has a Forward P/S ratio of 4.35. This means the market is valuing PRCT at $4.35 for every dollar of expected revenue over the next 12 months.

PRCT Valuation